Registered Nurse in Mercer Island, WA Accepting Medicare
5 Registered Nurse nurses found. Showing 1 - 5
 Robin H Fontana, ARNP Registered Nurse - Gerontology Medicare: Accepting Medicare Assignments Practice Location: 9725 Se 36th St, Suite 214, Mercer Island, WA 98040 Phone: 206-275-3588 Fax: 206-275-2073 |
Karen Sue Feldt, ARNP Registered Nurse - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 2960 76th Ave Se, Mercer Island, WA 98040 Phone: 206-941-0945 Fax: 206-236-1538 |
Kiny Chea, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4406 E Mercer Way, Mercer Island, WA 98040 Phone: 206-617-9109 |
Melissa C Chasan, R.N. Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 8416 Se 53rd Pl, Mercer Island, WA 98040 Phone: 206-236-6782 |
Ms. Boyon Yun, ARNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3236 78th Ave Se Ste 200, Mercer Island, WA 98040 Phone: 206-275-5060 Fax: 206-275-5061 |
News Archive
NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Pastoral support, not life-prolonging care, improves QoL at end of life
Quality of life at the end of life is improved when advanced cancer patients avoid being hospitalized, when their worry is reduced, they are given pastoral as well as medical care, and when they feel they are in alliance with their physician, show results of the Coping With Cancer study.
TWi Biotechnology gets notice of patent allowance covering use of AC-201 drug in diabetes treatment
TWi Biotechnology, Inc., today announced that it has received Notices of Allowance for AC-201, TWi Biotechnology's lead drug candidate, from the European Patent Office and the Patent Office of the Russian Federation for patent applications numbered 11766702.2-1460 and 2012147449, respectively.
Scientists identify 'molecular barcode' in blood samples that can predict survival of Ebola patients
Scientists have identified a 'molecular barcode' in the blood of patients with Ebola virus disease that can predict whether they are likely to survive or die from the viral infection.
› Verified 3 days ago